The Ho Chi Minh City Department of Health just decided to issue an urgent guildlines in terms of caring for people with COVID-19 who isolated at home. In this list, Cuu Long Pharmaceutical Joint Stock Company (DCL) – a member of FIT Group is prepared to supply to the market 2/5 items: Paracetamol 500mg tablets, capsules, effervescent tablets and Methyl Prednisolone 16mg
Specifically, the Ho Chi Minh City Department of Health prescribed Covid-19 treatment at home for adults, including fever-reducing, health-enhancing (vitamins, micronutrients, traditional medicine), antiviral, oral corticosteroids and anti-inflammatory in certain indications (for antiviral drugs alone, there will be users instructions as guided by the Ministry of Health).
Using indications of oral corticosteroids and anticoagulants: patients with early symptoms of respiratory failure (feeling of shortness of breath and/or respiratory rate > 20 breaths/minute and/or SpO2 < 95%, if any) and have not been able to contact medical staff for guidance and support.
The list in the prescription for Covid-19 home treatment of the Department of Health of Ho Chi Minh City.
Based on more than 40 years of operation experience as well as modern production lines meeting GMP-WHO standards, DCL is currently providing the market with many quality and reputable product lines, pharmacies and hospitals across the country. In which there are 2 product lines, Paracetamol 500mg tablets, capsules, effervescent tablets with the brand names of Panaga effer 500 and Panagal 500 and Methyl Prednisolone 16mg with the brand name
m-Rednisone 16 which are in the category of Covid-19 home treatment guidelines issued by the Health Department of Ho Chi Minh City.
DCL’s products are in the category of prescriptions for home treatment of Covid-19 issued by the Department of Health of Ho Chi Minh City.
Aside from that, in March 2021, DCL also started construction of Benovas Medical Equipment Factory with a total investment of about 15 million USD. The factory is built into 2 phases, phase 1 has a designed capacity of 35 million products/month; Phase 2 has a capacity of 20 million products/month with products including: Syringes, needles, infusion lines, butterfly needles, intravenous needles… These products are manufactured on modern production lines in the direction of automation meeting CE standards of Europe and FDA of the United States.
After going into operation in the first quarter of 2022, the products of Benovas Medical Equipment Factory not only better meet the needs of customers, but also contribute to providing a large amount of medical equipment to the public for the Covid-19 vaccination is currently being implemented. Besides, these products will be exported to European and US markets. Expected revenue of Benovas Medical Equipment Factory reaches VND 500 billion by 2025.
In the first 6 months of 2021, DCL’s consolidated profit before tax reached over VND 56.2 billion, an increase of VND 22.5 billion, equivalent to over 66% compared to the same period in 2020.
With this encouraging result, it can be said that 2021 is a breakthrough year for DCL’s profit with a revenue target of VND 805 billion, pre-tax profit of over VND 110 billion, up nearly 30% compared to 2020.
